Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy

Publication date: Available online 31 May 2017
Source:Brain and Development
Author(s): Tetsushi Yamamoto, Mariko Taniguchi-Ikeda, Hiroyuki Awano, Masaaki Matsumoto, Tomoko Lee, Risa Harada, Takamitsu Imanishi, Nobuhide Hayashi, Yoshitada Sakai, Ichiro Morioka, Yasuhiro Takeshima, Kazumoto Iijima, Jun Saegusa, Tatsushi Toda
BackgroundOne of the main complications in patients with muscular dystrophies is cardiac dysfunction. The literature on cardiac involvement in patients with Fukuyama congenital muscular dystrophy (FCMD) is limited.AimTo compare cardiac involvement between patients with FCMD and Duchenne muscular dystrophy (DMD).MethodsWe compared cardiac involvement between 30 patients with FCMD and 181 patients with DMD using echocardiography and serum biomarkers. All patients were receiving regular checkups at Kobe University Hospital. We used single regression analysis to compare echocardiographic parameters, age, and serum biomarkers.ResultsAlmost all clinical and echocardiographic parameters were lower in patients with FCMD than DMD. The brain natriuretic peptide concentration in patients with FCMD showed no correlation with age or left ventricular ejection fraction (r=0.231, p=0.22 and r=0.058, p=0.76, respectively). A log-rank test revealed that the risk of left ventricular systolic dysfunction was lower in patients with FCMD than DMD (p=0.046, hazard ratio=0.348).ConclusionThe clinical progression of cardiac dysfunction is significantly milder in patients with FCMD than DMD, while skeletal muscle involvement is significantly worse in patients with FCMD. These data suggest that the pathophysiological findings of FCMD can be explained by less severe cardiac dysfunction in FCMD than DMD.



http://ift.tt/2ruOXV2